Over the next 5 years, Jaleva is well positioned to accelerate its growth as a specialty pharmaceutical company. The Company is working to develop and license a deep pipeline of drug products focused on large markets. Its technology can be applied to a number of indications including, infections caused by fungus, bacteria, viruses and parasites; inflammatory skin disorders; transdermal applications: pain and pain management; delivery of hormones and certain steroids; cosmetics, including moisturizers and water resistant make-up; administration of transdermal nicotine to aid in smoking cessation.
We seek to license or partner with a firm that has a desire to market almost any dermatological topical medication with our superior delivery system of the active ingredient.
Our FDA routes are short since we typically enter a marketplace with an active ingredient already approved by the FDA.
Our IP is strong and covers our technology broadly.
